Novo Nordisk Eli Lilly - Search News

Novo NordiskEli Lilly

Novo slashes price on Wegovy

· 2h · on MSN

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

· 6h · on MSN

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

· 3h · on MSN

Novo Nordisk slashes Wegovy price for patients lacking insurance benefits

3h

Hims & Hers’ weight loss strategy validated by Novo DTC offering, says BofA

BofA analyst Allen Lutz reiterated an Underperform rating and $21 price target on Hims & Hers (HIMS) after Novo Nordisk (NVO) announced

Some results have been hidden because they may be inaccessible to you

Show inaccessible results